Related Experiment Video

Updated: Jun 5, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

295

Severe acute pulmonary embolism in pregnancy

Bhaskar Narayan1

  • 1Royal Surrey NHS Foundation Trust, Guildford, Surrey, UK.

Clinical Medicine (London, England)
|December 15, 2024
PubMed

Insights

Pulmonary embolism (PE) in pregnancy requires prompt diagnosis and risk stratification. Management includes anticoagulation with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH), with thrombolysis reserved for severe cases.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Pulmonology

Background:

  • Pulmonary embolism (PE) poses significant risks during pregnancy and postpartum.
  • Severe PE can lead to hemodynamic instability and cardiac arrest.
  • Risk stratification is crucial for managing acute PE.

Purpose of the Study:

  • To outline diagnostic and management strategies for intermediate- and high-risk PE in pregnancy.
  • To emphasize the applicability of existing PE risk criteria in pregnant patients.
  • To discuss safe and effective treatment options for PE during pregnancy and breastfeeding.

Main Methods:

  • Focuses on risk stratification criteria for intermediate- and high-risk PE.
  • Highlights the importance of timely diagnostic imaging, irrespective of pregnancy.
  • Reviews the use of anticoagulants (LMWH, UFH) and thrombolysis in obstetric patients.

Main Results:

  • High-risk PE criteria are applicable in pregnancy.
  • Diagnostic imaging should not be delayed.
  • LMWH and UFH are safe during pregnancy and breastfeeding.
  • Systemic thrombolysis is an option for severe, high-risk PE with shock, but carries bleeding risks.

Conclusions:

  • Pregnancy and the puerperium are risk factors for PE.
  • Avoid premature diagnostic closure; consider alternative diagnoses.
  • Appropriate risk stratification and timely intervention are key for managing PE in pregnant patients.

Keywords:
PostpartumPregnancyPulmonary embolismThrombolysisVTE

More Related Videos

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

12.2K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots07:57

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

268

Related Concept Videos

Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
169
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
120
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
173
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
1